NEW YORK, Dec. 30, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Medbox, Inc. ("Medbox" or the "Company") (OTC: MDBX), concerning whether the board has breached its fiduciary duties to shareholders.
On December 30, 2014, Medbox announced that its financial statements for the year ended December 31, 2013, the third and fourth quarters of 2013, and the first three quarters of 2014 would need to be restated and should no longer be relied on.
In October 2014, the Board of Directors of Medbox announced an internal investigation into a federal grand jury subpoena served on the Company's accountants and certain other alleged wrongdoing raised by a former employee of Medbox. The Company has since received subpoenas from the federal grand jury and the Securities and Exchange Commission.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Medbox shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400, (212)935-7400
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP